Your search returned 49 studies. (Get alerts for new studies):
- A Safety and Efficacy Study of the Birmingham Hip Resurfacing System
Conditions: Arthritis
Location: Lake Charles, Louisiana
- A Paroxetine- and Placebo-Controlled Study of 50 mg/Day and 100 mg/Day of EB-1010 Among Outpatients With Major Depressive Disorder Who Have Responded
Conditions: Major Depressive Disorder
Location: Lake Charles, Louisiana
- Safety and Efficacy of Cariprazine for Mania
Conditions: Bipolar Disorder - Mania
Location: Lake Charles, Louisiana
- Study to Evaluate Safety and Effectiveness of Oral Apremilast (CC-10004) in Patients With Moderate to Severe Plaque Psoriasis
Conditions: Plaque Psoriasis
Location: Lake Charles, Louisiana
- To Evaluate the Preliminary Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Efficacy of CC-11050 in Subjects With Discoid Lupus Erythemat
Conditions: Cutaneous Lupus Erythematosus
Location: Lake Charles, Louisiana
- Extension Study of Asenapine {P06107 (NCT01244815)} for Pediatric Bipolar Disorder (P05898 AM2)
Conditions: Bipolar Disorder
Location: Lake Charles, Louisiana
- A Physical Dependence Study in Schizophrenia
Conditions: Schizophrenia
Location: Lake Charles, Louisiana
- Study Evaluating The Efficacy And Safety Of Bapineuzumab In Alzheimer Disease Patients
Conditions: Alzheimer Disease
Location: Lake Charles, Louisiana
- A Long-Term Safety And Tolerability Extension Study Of Bapineuzumab In Alzheimer Disease Patients
Conditions: Alzheimer Disease
Location: Lake Charles, Louisiana
- SPD503 in Subjects Aged 6-17 Years With Generalized Anxiety Disorder (GAD), Separation Anxiety Disorder (SAD), or Social Phobia (SoP)
Conditions: Generalized Anxiety Disorder (GAD) - Anxiety, Separation - Phobia, Social
Location: Lake Charles, Louisiana
- Efficacy and Safety of Asenapine Treatment for Pediatric Bipolar Disorder {P06107 Has an Extension (P05898; NCT01349907}(P06107 AM2)
Conditions: Bipolar Disorder, Pediatric
Location: Lake Charles, Louisiana
- PEARL Schizophrenia Maintenance
Conditions: Schizophrenia
Location: Lake Charles, Louisiana
- Tritanium® Primary Acetabular Shell Study
Conditions: Osteoarthritis - Traumatic Arthritis - Avascular Necrosis
Location: Lake Charles, Louisiana
- A 6-Month Open-Label Extension Study to the B2061014 Study to Evaluate the Safety, Tolerability and Efficacy of DVS SR in the Treatment of Children an
Conditions: Major Depressive Disorder
Location: Lake Charles, Louisiana
- A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD
Conditions: Major Depressive Disorder
Location: Lake Charles, Louisiana
- Smoking Cessation Study In Healthy Adolescent Smokers
Conditions: Smoking Cessation
Location: Lake Charles, Louisiana
- Effect of Otamixaban Versus Unfractionated Heparin + Eptifibatide in Patients With Unstable Angina/Non ST Elevation Myocardial Infarction Undergoing E
Conditions: Acute Coronary Syndrome
Location: Lake Charles, Louisiana
- RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Conditions: Heart Failure - Anemia - Cardiovascular Disease - Ventricular Dysfunction - Congestive Heart Failure
Location: Lake Charles, Louisiana
- A Long-Term, Open-Label, Study on Schizophrenia
Conditions: Schizophrenia
Location: Lake Charles, Louisiana
- A Study of LY2140023 in Patients With Schizophrenia
Conditions: Schizophrenia
Location: Lake Charles, Louisiana
- Prospective Randomized Evaluation Of Celecoxib Integrated Safety Vs Ibuprofen Or Naproxen
Conditions: Arthritis, Rheumatoid - Osteoarthritis
Location: Beaumont, Texas
- RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Conditions: Heart Failure - Anemia - Cardiovascular Disease - Ventricular Dysfunction - Congestive Heart Failure
Location: Beaumont, Texas
- IGIV Study for Chronic ITP Patients Ages 3-70
Conditions: Idiopathic Thrombocytopenic Purpura
Location: Beaumont, Texas
- Randomized Phase II Trial of Letrozole With or Without Dasatinib as First and Second-line Treatment for Hormone Receptor-positive, HER2-negative Post-
Conditions: Metastatic Breast Cancer
Location: Beaumont, Texas
- Randomized Phase II Trial of Letrozole With or Without Dasatinib as First and Second-line Treatment for Hormone Receptor-positive, HER2-negative Post-
Conditions: Metastatic Breast Cancer
Location: Garland, Texas
- A Study of Pemetrexed, Carboplatin and Bevacizumab in Patients With Nonsquamous Non-Small Cell Lung Cancer
Conditions: Non-small Cell Lung Cancer
Location: Beaumont, Texas
- Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Conditions: Non-Small Cell Lung Cancer - Anemia - Cancer - Lung Cancer
Location: Beaumont, Texas
- Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression
Conditions: Bipolar - Depression
Location: Lake Charles, Louisiana
- Axitinib (AG-013736) For the Treatment of Metastatic Renal Cell Cancer
Conditions: Kidney Neoplasms
Location: Beaumont, Texas
- Continued HER2 Suppression With Lapatinib Plus Trastuzumab Versus Trastuzumab Alone
Conditions: Adenocarcinoma - Her2+ - Advanced Metastatic Breast Cancer - Metastatic ErbB2 - Invasive Breast Cancer - Advanced Breast Cancer - Cancer - ErbB2+
Location: Beaumont, Texas
- A Study of Chemotherapy and Ramucirumab vs. Chemotherapy Alone in Second Line Non-small Cell Lung Cancer Patients Who Received Prior First Line Platin
Conditions: Non Small Cell Lung Cancer
Location: Beaumont, Texas
- A Study in Second Line Metastatic Colorectal Cancer
Conditions: Colorectal Cancer
Location: Beaumont, Texas
- A Study of RO4917838 in Patients With Persistent, Predominant Negative Symptoms of Schizophrenia (WN25309)
Conditions: Schizophrenia
Location: Lake Charles, Louisiana
- A Study of RO4917838 in Patients With Acute Exacerbation of Schizophrenia
Conditions: Schizophrenia
Location: Lake Charles, Louisiana
- A Study of RO4917838 in Patients With Sub-optimally Controlled Symptoms of Schizophrenia (WN25306)
Conditions: Schizophrenia
Location: Lake Charles, Louisiana
- Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Conditions: Chronic Myeloid Leukemia
Location: Beaumont, Texas
- Eribulin With Trastuzumab as First-line Therapy for Locally Recurrent or Metastatic HER2 Positive Breast Cancer
Conditions: Breast Cancer
Location: Beaumont, Texas
- A Clinical Study in Patients With Overactive Bladder With Leakage of Urine, to Find Out if the Medicine, Fesoterodine, Works in Those Patients Who Did
Conditions: Overactive Bladder - Bladder, Overactive - Overactive Urinary Bladder
Location: Beaumont, Texas
- A Clinical Study in Patients With Overactive Bladder With Leakage of Urine, to Find Out if the Medicine, Fesoterodine, Works in Those Patients Who Did
Conditions: Overactive Bladder - Bladder, Overactive - Overactive Urinary Bladder
Location: Beaumont, Texas
- A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Conditions: Advanced Prostate Cancer - Prostatic Neoplasms
Location: Beaumont, Texas
- Cardiovascular Risk Reduction Study (Reduction in Recurrent Major CV Disease Events)
Conditions: Atherosclerosis
Location: Beaumont, Texas
- Cardiovascular Risk Reduction Study (Reduction in Recurrent Major CV Disease Events)
Conditions: Atherosclerosis
Location: Beaumont, Texas
- Efficacy Study of OPC-34712 in Adults With Acute Schizophrenia
Conditions: Acute Schizophrenia
Location: Lake Charles, Louisiana
- Safety and Tolerability Study of Oral OPC-34712 as Maintenance Treatment in Adults With Schizophrenia
Conditions: Schizophrenia
Location: Lake Charles, Louisiana
- A Long-Term Study in Schizophrenia
Conditions: Schizophrenia
Location: Lake Charles, Louisiana
- The BEACON Study (Breast Cancer Outcomes With NKTR-102)
Conditions: Locally Recurrent Breast Cancer - Metastatic Breast Cancer
Location: Beaumont, Texas
- Study of the Efficacy and Safety of the Combination of Two FDA Approved Oral Medications, Nebivolol and Valsartan for Treatment of Stage 1 or 2 Hypert
Conditions: Stage 1 Hypertension - Stage 2 Hypertension
Location: Beaumont, Texas
- A Twelve Week, Open Label Extension Study in Patients With Schizophrenia
Conditions: Schizophrenia
Location: Lake Charles, Louisiana
- 8-week Randomized, Open-label Study to Evaluate Food Effect on Efficacy and Safety of Oral Aliskiren 300 mg in Patients With Hypertension
Conditions: Hypertension
Location: Beaumont, Texas
|